Palline

About Palline

Shanghai Penghai Laixun Data Technology Co., Ltd., operating under the brand name Penglai Data (蓬海数据), is a data technology firm specializing in the healthcare sector in China. The company was established on June 1, 2010, and is legally represented by its founder, Wang Zhigang. Wang, who has a background in both medicine and finance, launched Penglai Data in 2014 to introduce the Resource-Based Relative Value Scale (RBRVS), a model for determining physician payment, into Chinese public hospitals. This venture was preceded by his 2007 role as CEO at a foreign-funded startup focused on data integration platforms, an experience that provided him with insights into the challenges and value of data integration.

Penglai Data provides an integrated hospital operation management platform designed to facilitate refined management through digital twin technology. The company's core business revolves around offering comprehensive solutions that include management concepts, tools, and data applications to enhance efficiency within medical settings. Its client base consists of various healthcare entities, including large-scale hospitals, medical communities, and regulatory bodies like the Health Commission. The business model is centered on providing software and data-driven services that address hospital performance evaluation, operational analysis, cost control, and resource allocation. Revenue is generated through the implementation of these solutions for hundreds of users.

The company's product suite is extensive, featuring systems for performance evaluation based on RBRVS and Diagnosis-Related Groups (DRGs), DRG/DIP evaluation and operation analysis systems, dynamic cost analysis, and specialty operation support systems. These tools are designed to create a resource allocation system centered on performance evaluation, helping hospitals integrate management tools and information technology into their workflows. A key offering is the performance evaluation product based on RBRVS, which was refined after collaborations with various provincial-level hospitals and finalized as version 2.0 in late 2015. By leveraging statistical methods and AI, Penglai Data has developed mathematical models for performance assessment, operational analysis, and strategic development, which have been implemented in numerous large hospitals. The firm has successfully raised significant capital, including a Series A+ funding round of several hundred million RMB in September 2022 and a Series A round of nearly 200 million RMB in February 2022.